Patents by Inventor Lawrence DEARTH

Lawrence DEARTH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY
    Publication number: 20240075133
    Abstract: Provided herein are methods and uses involving the combination of an anti-CD20 antibody, e.g., rituximab with a protein therapeutic, for example, an antibody (e.g., an antibody that specifically binds to human CD47).
    Type: Application
    Filed: June 15, 2023
    Publication date: March 7, 2024
    Inventors: Jeffrey C. Johnson, Lawrence Dearth, Haralambos HADJIVASSILIOU, Jeonghoon Sun, Kandasamy Hariharan
  • Antibodies with low immunogenicity and uses thereof
    Patent number: 11427632
    Abstract: Provided herein are antibodies and antigen-binding fragments thereof with low or no immunogenicity in humans and optionally with desirable manufacturing properties. Also provided are compositions comprising such antibodies or antigen-binding fragments, methods of using such antibodies, and methods for making such antibodies.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: August 30, 2022
    Assignee: CELGENE CORPORATION
    Inventors: Jeffrey C. Johnson, Lawrence Dearth, Haralambos Hadjivassiliou, Jeonghoon Sun, Kandasamy Hariharan
  • METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY
    Publication number: 20200330590
    Abstract: Provided herein are methods and uses involving the combination of an anti-CD20 antibody, e.g., rituximab with a protein therapeutic, for example, an antibody (e.g., an antibody that specifically binds to human CD47).
    Type: Application
    Filed: March 26, 2018
    Publication date: October 22, 2020
    Applicant: CELGENE CORPORATION
    Inventors: Jeffrey C. Johnson, Lawrence Dearth, Haralambos Vassiliou, Jeonghoon Sun, Kandasamy Hariharan
  • ANTIBODIES WITH LOW IMMUNOGENICITY AND USES THEREOF
    Publication number: 20190241654
    Abstract: Provided herein are antibodies and antigen-binding fragments thereof with low or no immunogenicity in humans and optionally with desirable manufacturing properties. Also provided are compositions comprising such antibodies or antigen-binding fragments, methods of using such antibodies, and methods for making such antibodies.
    Type: Application
    Filed: July 5, 2017
    Publication date: August 8, 2019
    Applicant: CELGENE CORPORATION
    Inventors: Jeffrey C. JOHNSON, Lawrence DEARTH, Haralambos HADJIVASSILIOU, Jeonghoon SUN, Kandasamy HARIHARAN